Literature DB >> 11205596

Associated morbidities in children with sickle-cell anaemia presenting with severe anaemia in a malarious area.

J P Ambe1, J O Fatunde, O O Sodeinde.   

Abstract

A prospective study of 104 consecutive cases of patients with sickle-cell anaemia (SCA) presenting with severe anaemia (packed cell volume < or = 15%) was carried out in the Children's Emergency Ward of the University College Hospital, Ibadan, in 1991. The patients were classified according to the type of anaemic crisis, by physical findings, serum bilirubin and reticulocyte counts. Other investigations included a blood film for malaria parasites, blood culture, radiological investigation and lumbar puncture when necessary. The most common problems associated with SCA patients in anaemic crisis were malaria and bacterial infections--68 (66%) and 18 (17.3%) of cases, respectively. Acute chest syndrome was significantly more frequent in patients with hyperhaemolytic and acute splenic sequestration crisis compared with aplastic crisis (P < 0.05). Conjugated hyperbilirubinaemia was also significantly more frequent among patients with hyperhaemolytic crisis compared with all other anaemic crises (chi2 = 13.18, P = 0.001). The overall case fatality was 86.5/1,000 SCAs, with no fatalities in those with aplastic crisis. There were complications in six of the nine mortalities. Co-existing bacterial infections and conjugated hyperbilirubinaemia were associated with increased morbidity and mortality in patients with anaemic crisis. Patients with SCA crisis should have early evaluation and prompt treatment for associated infections.

Entities:  

Mesh:

Year:  2001        PMID: 11205596     DOI: 10.1177/004947550103100109

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  15 in total

1.  High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya.

Authors:  Charlotte F McAuley; Clare Webb; Julie Makani; Alexander Macharia; Sophie Uyoga; Daniel H Opi; Carolyne Ndila; Antony Ngatia; John Anthony G Scott; Kevin Marsh; Thomas N Williams
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

Review 2.  Sickle cell disease in Africa: burden and research priorities.

Authors:  J Makani; T N Williams; K Marsh
Journal:  Ann Trop Med Parasitol       Date:  2007-01

3.  Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization.

Authors:  Julie Makani; Albert N Komba; Sharon E Cox; Julie Oruo; Khadija Mwamtemi; Jesse Kitundu; Pius Magesa; Stella Rwezaula; Elineema Meda; Josephine Mgaya; Kisali Pallangyo; Emelda Okiro; David Muturi; Charles R Newton; Gregory Fegan; Kevin Marsh; Thomas N Williams
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

4.  Malaria as a cause of morbidity and mortality in children with homozygous sickle cell disease on the coast of Kenya.

Authors:  Albert N Komba; Julie Makani; Manish Sadarangani; Tolu Ajala-Agbo; James A Berkley; Charles R J C Newton; Kevin Marsh; Thomas N Williams
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

5.  Naturally acquired hemozoin by monocytes promotes suppression of RANTES in children with malarial anemia through an IL-10-dependent mechanism.

Authors:  Tom Were; Gregory C Davenport; Emmanuel O Yamo; James B Hittner; Gordon A Awandare; Michael F Otieno; Collins Ouma; Alloys S S Orago; John M Vulule; John M Ong'echa; Douglas J Perkins
Journal:  Microbes Infect       Date:  2009-05-07       Impact factor: 2.700

Review 6.  Travelers with sickle cell disease.

Authors:  Shaina M Willen; Courtney D Thornburg; Paul M Lantos
Journal:  J Travel Med       Date:  2014-06-19       Impact factor: 8.490

7.  Effects of pyrimethamine versus proguanil in malarial chemoprophylaxis in children with sickle cell disease: a randomized, placebo-controlled, open-label study.

Authors:  Felicia U Eke; Ifeoma Anochie
Journal:  Curr Ther Res Clin Exp       Date:  2003-09

Review 8.  Sickle Cell Disease in Sub-Saharan Africa.

Authors:  Thomas N Williams
Journal:  Hematol Oncol Clin North Am       Date:  2016-01-28       Impact factor: 3.722

9.  A Randomized Trial to Compare the Safety, Tolerability, and Effectiveness of 3 Antimalarial Regimens for the Prevention of Malaria in Nigerian Patients With Sickle Cell Disease.

Authors:  Rasaq Olaosebikan; Kolade Ernest; Kalifa Bojang; Olugbenga Mokuolu; Andrea M Rehman; Muna Affara; Davis Nwakanma; Jean-René Kiechel; Taofik Ogunkunle; Tope Olagunju; Rukayat Murtala; Peter Omefe; Tosin Lambe; Surajudeen Bello; Olayinka Ibrahim; Benedict Olorunsola; Ayotade Ojuawo; Brian Greenwood; Paul Milligan
Journal:  J Infect Dis       Date:  2015-02-20       Impact factor: 5.226

10.  A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.

Authors:  George O Adjei; Bamenla Q Goka; Christabel C Enweronu-Laryea; Onike P Rodrigues; Lorna Renner; Abdul M Sulley; Michael Alifrangis; Insaf Khalil; Jorgen A Kurtzhals
Journal:  Malar J       Date:  2014-09-19       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.